We are live on ! Find out more
AIM

Alerce Investment Management Portfolio holdings

AUM $56.8M
1-Year Est. Return 31.17%
This Fund
S&P 500
This Quarter Est. Return
-19.44%
1 Year Est. Return
+31.17%
3 Year Est. Return
+25.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$146M
AUM Growth
-$38.1M
Cap. Flow
-$122
Cap. Flow %
-0%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
WHWK
Whitehawk Therapeutics
WHWK
+$122

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMWL icon
1
American Well
AMWL
$180M
$57.4M 39.29%
315,039
– –
ANNX icon
2
Annexon
ANNX
$834M
$36.4M 24.9%
1,954,978
– –
RNTX
3
Rein Therapeutics
RNTX
$63.1M
$16.9M 11.6%
830,472
– –
AKBA icon
4
Akebia Therapeutics
AKBA
$354M
$13.4M 9.17%
4,652,561
– –
WHWK
5
Whitehawk Therapeutics
WHWK
$190M
$11M 7.53%
374,785
-4
-0% -$122
ASMB icon
6
Assembly Biosciences
ASMB
$498M
$7.75M 5.31%
185,625
– –
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3.22M 2.2%
126,270
– –

Similar funds

CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
AFA
Atlas Financial Advisors Oroville, California $64.1M AUM 8.36% 1-Year Est. Return
MCC
Maiden Cove Capital Cape Elizabeth, Maine $65.4M AUM
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return
MC
Meketa Capital Westwood, Massachusetts $44.6M AUM
OAM
Origin Asset Management London, United Kingdom $43.5M AUM 31.63% 1-Year Est. Return
IP
Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return
JCP
Jennifer C. Price $75.5M AUM 6.25% 1-Year Est. Return

Alerce Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, Alerce Investment Management held 7 positions worth $146M, down 21% from $184M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 0%. Alerce Investment Management opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Alerce Investment Management's biggest Q3 2021 reduction was Whitehawk Therapeutics, cutting an estimated $122.
  • Alerce Investment Management's ten largest holdings make up 100% of its $146M portfolio in Q3 2021.
  • Alerce Investment Management opened 0 new positions and closed 0 in Q3 2021.
  • Alerce Investment Management's portfolio value fell 21% quarter-over-quarter to $146M.

Based on Alerce Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.